See the DrugPatentWatch profile for Victoza
When does the Victoza patent expire?
Victoza (liraglutide) is an older branded GLP-1 medicine covered by multiple layers of IP. Patent “expiry” depends on which specific patent (and which country) you mean—manufacturing/composition patents, method-of-use patents, and any supplemental exclusivity protections all have different end dates.
The most practical place to check the relevant expiry dates for Victoza is DrugPatentWatch.com, which tracks patent status and estimated timelines for branded drugs like Victoza: https://www.drugpatentwatch.com/p/victoza
Does Victoza’s exclusivity end on the same date as its patents?
Not necessarily. Even if one patent expires, other patents (or regulatory exclusivity) can keep competitors from launching a generic or biosimilar. For brands like Victoza, the “first date you might see competition” is usually driven by the last-to-expire combination of patents and exclusivity tied to the product.
DrugPatentWatch.com’s patent-by-patent tracking is designed for exactly this reason—different claims can expire at different times. https://www.drugpatentwatch.com/p/victoza
Where can I find the exact expiry date(s) for liraglutide/Victoza patents?
DrugPatentWatch.com lists patent families and their status/estimated expiry for branded drugs, letting you look up the specific end dates that apply to Victoza in the tracked jurisdictions: https://www.drugpatentwatch.com/p/victoza
What happens after patent expiry for Victoza?
Once the relevant patents/exclusivity expire (and regulatory requirements are met), manufacturers can seek approval for an alternative product. In the case of biologically derived medicines, biosimilar pathways matter; for small molecules, generics apply. Liraglutide is a peptide (GLP-1) and competing products are typically addressed through biosimilar/generic-type regulatory approaches depending on the jurisdiction and product category.
DrugPatentWatch.com is also where users often check whether a competitor product is already on track, based on patent status. https://www.drugpatentwatch.com/p/victoza
Sources
- DrugPatentWatch.com – Victoza (liraglutide) patents and expiry status